Related Experiment Video

Updated: Dec 12, 2025

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
04:40

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Published on: August 28, 2018

15.7K

Management of calcified coronary artery bifurcation lesions

Nileshkumar J Patel1, Naotaka Okamoto1, Jonathan Murphy1

  • 1Division of Cardiology, Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai, New York.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|August 11, 2020
PubMed

Insights

Treating calcified coronary artery bifurcation lesions (CBL) is challenging due to limited evidence. This review simplifies CBL treatment strategies, emphasizing plaque modification and a new mobile app, BifurcAID, for guidance.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research
  • Medical Device Technology

Background:

  • Calcified coronary artery bifurcation lesions (CBL) present significant challenges in interventional cardiology.
  • Current evidence and established treatment guidelines for CBL are notably limited.
  • Effective plaque modification is crucial before stent implantation in these complex lesions.

Purpose of the Study:

  • To present a simplified, contemporary approach for managing calcified coronary artery bifurcation lesions.
  • To illustrate treatment strategies for CBL through practical case examples.
  • To introduce and demonstrate the utility of a novel mobile application, BifurcAID, in managing CBL.

Main Methods:

  • A comprehensive review of current literature and interventional strategies for CBL.
  • Development and application of a mobile tool (BifurcAID) for decision support in CBL treatment.
  • Case-based demonstration of the proposed simplified approach to CBL management.

Main Results:

  • Provisional stenting is recommended as the primary strategy for most bifurcation lesions.
  • A two-stent strategy is advised for specific complex cases involving large side branches, severe stenosis, or long lesions.
  • The BifurcAID application provides a structured framework for applying treatment guidelines to specific patient scenarios.

Conclusions:

  • A simplified, evidence-informed approach can improve the management of challenging calcified coronary artery bifurcation lesions.
  • The judicious use of a two-stent strategy is essential in select complex bifurcation cases.
  • Mobile applications like BifurcAID can aid interventional cardiologists in decision-making and treatment planning for CBL.

Keywords:
atherectomybifurcationcalcified stenosisleft main

More Related Videos

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.0K
Novel and Innovative Hybrid Technique for Type A Aortic Dissection06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

722

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
161
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
151
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
160
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
226
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
153
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
250